Injection of soluble RAGE into the brain of an Alzheimeŕs disease mouse model reduced the levels of Aβ, Aβ plaques and BACE1 (beta-site APP Cleaving Enzyme 1) [13]. The gene discussed is BACE1; the disease is glycogen storage disease VI.